Provided by Tiger Fintech (Singapore) Pte. Ltd.

Milestone Pharmaceuticals Inc.

2.20
-0.1800-7.56%
Volume:1.52M
Turnover:3.41M
Market Cap:117.38M
PE:-2.90
High:2.38
Open:2.37
Low:2.18
Close:2.38
Loading ...

Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil

GlobeNewswire
·
19 Feb

Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025

GlobeNewswire
·
11 Feb

Loss-Making Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Expected To Breakeven In The Medium-Term

Simply Wall St.
·
03 Feb

A Hewlett Packard exec sent a dramatic ‘KILL MIST’ email during its aggressive campaign to crush a rival, court docs revealed. Now HP wants to buy it for $14 billion

Fortune
·
31 Jan

BRIEF-Milestone Pharmaceuticals Provides 2025 Corporate Outlook And To Host Investor Event On Feb 25 In NYC

Reuters
·
28 Jan

Milestone Pharmaceuticals Inc: Pdufa Date of March 27, 2025 for Cardamyst™ (Etripamil) Nasal Spray

THOMSON REUTERS
·
28 Jan

Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in Nyc

THOMSON REUTERS
·
28 Jan

Milestone Pharmaceuticals Inc: Plans to Initiate Phase 3 Study in Afib-Rvr in H1 2025

THOMSON REUTERS
·
28 Jan

Milestone Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
27 Jan

Milestone Pharmaceuticals reports inducement grants under Nasdaq listing rule

TIPRANKS
·
07 Jan

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
07 Jan

Milestone Pharmaceuticals to Present at the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire
·
25 Nov 2024

After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook is Bright

Zacks
·
19 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 Nov 2024

BRIEF-Milestone Pharmaceuticals Files For Mixed Shelf Offering Of Up To $250 Million - SEC Filing

Reuters
·
13 Nov 2024

Milestone Pharmaceuticals Files for Mixed Shelf Offering of up to $250 Mln - SEC Filing

THOMSON REUTERS
·
13 Nov 2024